U.S. Pharmaceuticals & Biotech Most Popular Stocks

Eli Lilly

Market Cap: US$666.0b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$425.5b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

AbbVie

Market Cap: US$388.6b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$199.0b

Operates as a healthcare company worldwide.

Thermo Fisher Scientific

Market Cap: US$176.7b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Amgen

Market Cap: US$150.3b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Gilead Sciences

Market Cap: US$141.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Pfizer

Market Cap: US$137.0b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Danaher

Market Cap: US$133.1b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Vertex Pharmaceuticals

Market Cap: US$96.6b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Bristol-Myers Squibb

Market Cap: US$89.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Zoetis

Market Cap: US$62.8b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$60.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Regeneron Pharmaceuticals

Market Cap: US$59.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

BeOne Medicines

Market Cap: US$36.3b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Agilent Technologies

Market Cap: US$35.3b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

IQVIA Holdings

Market Cap: US$30.8b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Insmed

Market Cap: US$29.8b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Mettler-Toledo International

Market Cap: US$25.6b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

BioNTech

Market Cap: US$24.0b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Natera

Market Cap: US$22.5b

A diagnostics company, provides molecular testing services worldwide.

Teva Pharmaceutical Industries

Market Cap: US$22.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Royalty Pharma

Market Cap: US$20.9b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Biogen

Market Cap: US$20.2b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

United Therapeutics

Market Cap: US$19.8b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

West Pharmaceutical Services

Market Cap: US$18.7b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Waters

Market Cap: US$17.4b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Incyte

Market Cap: US$16.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Summit Therapeutics

Market Cap: US$15.2b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Neurocrine Biosciences

Market Cap: US$14.5b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Illumina

Market Cap: US$14.5b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Medpace Holdings

Market Cap: US$14.0b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Tempus AI

Market Cap: US$13.8b

Operates as a healthcare technology company.

ICON

Market Cap: US$13.0b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Ascendis Pharma

Market Cap: US$11.7b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Viatris

Market Cap: US$11.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.